195 related articles for article (PubMed ID: 22240760)
1. Differential effects of trimetazidine on vascular smooth muscle cell and endothelial cell in response to carotid artery balloon injury in diabetic rats.
Yoon JW; Cho BJ; Park HS; Kang SM; Choi SH; Jang HC; Shin H; Lee MJ; Kim YB; Park KS; Lim S
Int J Cardiol; 2013 Jul; 167(1):126-33. PubMed ID: 22240760
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of carotid neointimal formation after direct delivery of a recombinant adenovirus expressing glucagon-like peptide-1 in diabetic rats.
Lim S; Lee GY; Park HS; Lee DH; Tae Jung O; Kyoung Min K; Kim YB; Jun HS; Hak Chul J; Park KS
Cardiovasc Res; 2017 Feb; 113(2):183-194. PubMed ID: 27702762
[TBL] [Abstract][Full Text] [Related]
3. Puerarin accelerates re-endothelialization in a carotid arterial injury model: impact on vasodilator concentration and vascular cell functions.
Cheng M; Li X; Guo Z; Cui X; Li H; Jin C; Zhang X; Guan X
J Cardiovasc Pharmacol; 2013 Oct; 62(4):361-8. PubMed ID: 23792702
[TBL] [Abstract][Full Text] [Related]
4. Nicorandil attenuates carotid intimal hyperplasia after balloon catheter injury in diabetic rats.
Zhang YQ; Tian F; Zhou Y; Chen YD; Li B; Ma Q; Zhang Y
Cardiovasc Diabetol; 2016 Apr; 15():62. PubMed ID: 27059601
[TBL] [Abstract][Full Text] [Related]
5. Exogenous SERP1 attenuates restenosis by restoring GLP-1 receptor activity in diabetic rats following vascular injury.
Feng L; Wang J; Ma X
Biomed Pharmacother; 2018 Jul; 103():290-300. PubMed ID: 29656185
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human interleukin-10 inhibits proliferation of vascular smooth muscle cells stimulated by advanced glycation end products and neointima hyperplasia after carotid injury in the rat.
Ouyang P; Peng LS; Yang H; Peng WL; Wu WY; Xu AL
Sheng Li Xue Bao; 2003 Apr; 55(2):128-34. PubMed ID: 12715099
[TBL] [Abstract][Full Text] [Related]
7. The interleukin-1β modulator gevokizumab reduces neointimal proliferation and improves reendothelialization in a rat carotid denudation model.
Roubille F; Busseuil D; Shi Y; Nachar W; Mihalache-Avram T; Mecteau M; Gillis MA; Brand G; Théberge-Julien G; Brodeur MR; Kernaleguen AE; Gombos M; Rhéaume E; Tardif JC
Atherosclerosis; 2014 Oct; 236(2):277-85. PubMed ID: 25108619
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of neointimal formation after balloon injury by cilostazol, accompanied by improvement of endothelial dysfunction and induction of hepatocyte growth factor in rat diabetes model.
Aoki M; Morishita R; Hayashi S; Jo N; Matsumoto K; Nakamura T; Kaneda Y; Ogihara T
Diabetologia; 2001 Aug; 44(8):1034-42. PubMed ID: 11484082
[TBL] [Abstract][Full Text] [Related]
9. Cilostazol suppression of arterial intimal hyperplasia is associated with decreased expression of sialyl Lewis X homing receptors on mononuclear cells and E-selectin in endothelial cells.
Takigawa T; Tsurushima H; Suzuki K; Tsuruta W; Nakamura K; Matsumura A
J Vasc Surg; 2012 Feb; 55(2):506-16. PubMed ID: 22264805
[TBL] [Abstract][Full Text] [Related]
10. Effect of a dipeptidyl peptidase-IV inhibitor, des-fluoro-sitagliptin, on neointimal formation after balloon injury in rats.
Lim S; Choi SH; Shin H; Cho BJ; Park HS; Ahn BY; Kang SM; Yoon JW; Jang HC; Kim YB; Park KS
PLoS One; 2012; 7(4):e35007. PubMed ID: 22493727
[TBL] [Abstract][Full Text] [Related]
11. Cinaciguat prevents neointima formation after arterial injury by decreasing vascular smooth muscle cell migration and proliferation.
Hirschberg K; Tarcea V; Páli S; Barnucz E; Gwanmesia PN; Korkmaz S; Radovits T; Loganathan S; Merkely B; Karck M; Szabó G
Int J Cardiol; 2013 Jul; 167(2):470-7. PubMed ID: 22357420
[TBL] [Abstract][Full Text] [Related]
12. Activation of Peroxisome Proliferator-Activated Receptor-δ as Novel Therapeutic Strategy to Prevent In-Stent Restenosis and Stent Thrombosis.
Hytönen J; Leppänen O; Braesen JH; Schunck WH; Mueller D; Jung F; Mrowietz C; Jastroch M; von Bergwelt-Baildon M; Kappert K; Heuser A; Drenckhahn JD; Pieske B; Thierfelder L; Ylä-Herttuala S; Blaschke F
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1534-48. PubMed ID: 27283742
[TBL] [Abstract][Full Text] [Related]
13. Glucagon-Like Peptide-1 Receptor Activation Does not Affect Re-Endothelialization but Reduces Intimal Hyperplasia via Direct Effects on Smooth Muscle Cells in a Nondiabetic Model of Arterial Injury.
Eriksson L; Saxelin R; Röhl S; Roy J; Caidahl K; Nyström T; Hedin U; Razuvaev A
J Vasc Res; 2015; 52(1):41-52. PubMed ID: 25966620
[TBL] [Abstract][Full Text] [Related]
14. Linarin Ameliorates Restenosis After Vascular Injury in Type 2 Diabetes Mellitus via Regulating ADAM10-Mediated Notch Signaling Pathway.
Jiang A; Liu L; Wang J; Liu Y; Deng S; Jiang T
Cardiovasc Toxicol; 2024 Jun; 24(6):587-597. PubMed ID: 38691303
[TBL] [Abstract][Full Text] [Related]
15. Adenosine A₂B receptor agonism inhibits neointimal lesion development after arterial injury in apolipoprotein E-deficient mice.
Bot I; de Vries H; Korporaal SJ; Foks AC; Bot M; van Veldhoven J; Ter Borg MN; van Santbrink PJ; van Berkel TJ; Kuiper J; Ijzerman AP
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2197-205. PubMed ID: 22743060
[TBL] [Abstract][Full Text] [Related]
16. Tissue factor pathway inhibitor-2 is induced by fluid shear stress in vascular smooth muscle cells and affects cell proliferation and survival.
Ekstrand J; Razuvaev A; Folkersen L; Roy J; Hedin U
J Vasc Surg; 2010 Jul; 52(1):167-75. PubMed ID: 20537494
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol inhibits phenotypic switching of neointimal vascular smooth muscle cells after balloon injury through blockade of Notch pathway.
Zhang J; Chen J; Xu C; Yang J; Guo Q; Hu Q; Jiang H
J Cardiovasc Pharmacol; 2014 Mar; 63(3):233-9. PubMed ID: 24603118
[TBL] [Abstract][Full Text] [Related]
18. The cyclolignan picropodophyllin attenuates intimal hyperplasia after rat carotid balloon injury by blocking insulin-like growth factor-1 receptor signaling.
Razuvaev A; Henderson B; Girnita L; Larsson O; Axelson M; Hedin U; Roy J
J Vasc Surg; 2007 Jul; 46(1):108-15. PubMed ID: 17606126
[TBL] [Abstract][Full Text] [Related]
19. Vasculoprotective Effects of 3-Hydroxybenzaldehyde against VSMCs Proliferation and ECs Inflammation.
Kong BS; Im SJ; Lee YJ; Cho YH; Do YR; Byun JW; Ku CR; Lee EJ
PLoS One; 2016; 11(3):e0149394. PubMed ID: 27002821
[TBL] [Abstract][Full Text] [Related]
20. Local cyclin-dependent kinase inhibition by flavopiridol inhibits coronary artery smooth muscle cell proliferation and migration: Implications for the applicability on drug-eluting stents to prevent neointima formation following vascular injury.
Jaschke B; Milz S; Vogeser M; Michaelis C; Vorpahl M; Schömig A; Kastrati A; Wessely R
FASEB J; 2004 Aug; 18(11):1285-7. PubMed ID: 15180955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
